DK233390A - Mutant humant angiogenin (angiogenese-faktor med hoej angiogeninaktivitet), gener derfor og metoder til ekspression - Google Patents

Mutant humant angiogenin (angiogenese-faktor med hoej angiogeninaktivitet), gener derfor og metoder til ekspression Download PDF

Info

Publication number
DK233390A
DK233390A DK233390A DK233390A DK233390A DK 233390 A DK233390 A DK 233390A DK 233390 A DK233390 A DK 233390A DK 233390 A DK233390 A DK 233390A DK 233390 A DK233390 A DK 233390A
Authority
DK
Denmark
Prior art keywords
mutant
angiogenic
proteins
angiogenin
angiogenine
Prior art date
Application number
DK233390A
Other languages
English (en)
Other versions
DK233390D0 (da
Inventor
Jeffrey W Harper
Bert L Vallee
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DK233390D0 publication Critical patent/DK233390D0/da
Publication of DK233390A publication Critical patent/DK233390A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK233390A 1988-03-28 1990-09-27 Mutant humant angiogenin (angiogenese-faktor med hoej angiogeninaktivitet), gener derfor og metoder til ekspression DK233390A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/173,760 US4900673A (en) 1988-03-28 1988-03-28 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
PCT/US1989/001150 WO1989009277A1 (en) 1988-03-28 1989-03-20 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression

Publications (2)

Publication Number Publication Date
DK233390D0 DK233390D0 (da) 1990-09-27
DK233390A true DK233390A (da) 1990-11-26

Family

ID=22633370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233390A DK233390A (da) 1988-03-28 1990-09-27 Mutant humant angiogenin (angiogenese-faktor med hoej angiogeninaktivitet), gener derfor og metoder til ekspression

Country Status (13)

Country Link
US (1) US4900673A (da)
EP (1) EP0335243B1 (da)
JP (1) JPH03503641A (da)
KR (1) KR900700609A (da)
AT (1) ATE96844T1 (da)
AU (1) AU621358B2 (da)
CA (1) CA1331356C (da)
DE (1) DE68910354T2 (da)
DK (1) DK233390A (da)
IE (1) IE890954L (da)
PT (1) PT90129A (da)
WO (1) WO1989009277A1 (da)
ZA (1) ZA892270B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520914A (en) * 1987-08-06 1996-05-28 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
IL96519A0 (en) * 1990-02-15 1991-08-16 Harvard College Covalent angiogenin/rnase hybrids
DE4309391C2 (de) * 1993-03-23 1996-10-24 Harald Prof Dr Tschesche Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten
WO2000053753A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
WO2000015792A2 (en) * 1998-09-14 2000-03-23 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
WO2001019987A1 (en) * 1999-09-13 2001-03-22 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US6321109B2 (en) 1996-02-15 2001-11-20 Biosense, Inc. Catheter based surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
WO2001040464A1 (en) * 1999-11-30 2001-06-07 Genentech, Inc. Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization
US5852001A (en) * 1996-12-23 1998-12-22 The Endowment For Research In Human Biology Method and compounds for inhibition of ribonucleases
WO2000053752A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
EP1563866B1 (en) 1998-02-05 2007-10-03 Biosense Webster, Inc. Intracardiac drug delivery
US6211157B1 (en) 1998-05-01 2001-04-03 Sulzer Biologics, Inc. Protein mixtures to induce therapeutic angiogenesis
US6992066B2 (en) * 1998-10-16 2006-01-31 Zimmer Orthobiologics, Inc. Povidone-containing carriers for polypeptide growth factors
US7087577B2 (en) * 1998-10-16 2006-08-08 Zimmer Orthobiologies, Inc. Method of promoting natural bypass
AU771751C (en) * 1998-12-01 2006-04-06 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
EP1734051A3 (en) * 1998-12-01 2007-09-12 Genetech, Inc. Composition and methods for the diagnosis of tumours
JP2003531811A (ja) * 1999-03-08 2003-10-28 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
US6743600B1 (en) 1999-04-30 2004-06-01 Monsanto Technologies Llc Method of removing N-terminal alanine residues from polypeptides with Aeromonas aminopeptidase
US6794159B1 (en) * 1999-04-30 2004-09-21 Pharmacia Corporation Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
ATE393825T1 (de) * 1999-06-02 2008-05-15 Genentech Inc Stimulierung oder hemmung von angiogenese und herzvaskularisierung
CA2412211A1 (en) * 2000-06-23 2002-01-03 Genetech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US7232802B2 (en) * 2001-12-21 2007-06-19 Zimmer Orthobiologics, Inc. Compositions and methods for promoting myocardial and peripheral angiogenesis
WO2004106491A2 (en) * 2003-05-22 2004-12-09 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Angiogenin-based hiv-1 therapies
GB0425625D0 (en) 2004-11-22 2004-12-22 Royal College Of Surgeons Ie Treatment of disease
US8828698B2 (en) * 2007-04-12 2014-09-09 Naidu Lp Immobilized angiogenin mixtures and uses thereof
US7601689B2 (en) * 2007-04-12 2009-10-13 Naidu Lp Angiogenin complexes (ANGex) and uses thereof
WO2011062762A2 (en) * 2009-11-19 2011-05-26 President And Fellows Of Harvard College Angiogenin and variants thereof for treatment of neurodegenerative diseases
CN115947818B (zh) * 2022-10-25 2024-08-02 福州大学 一种血管生成素1突变体的设计及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721672A (en) * 1985-08-28 1988-01-26 President And Fellows Of Harvard College CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression
IL80944A (en) * 1985-12-17 1994-10-07 Synergen Inc Boulder Colo U S A factor in the formation of blood vessels in a human placenta capable of inducing protease synthesis in the inner lining of capillary cells, DNA synthesis. And migration of materials
FR2623509B1 (fr) * 1987-11-19 1990-04-20 Centre Nat Rech Scient Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments

Also Published As

Publication number Publication date
PT90129A (pt) 1989-11-10
DE68910354D1 (de) 1993-12-09
WO1989009277A1 (en) 1989-10-05
DE68910354T2 (de) 1994-03-03
IE890954L (en) 1989-09-28
JPH03503641A (ja) 1991-08-15
US4900673A (en) 1990-02-13
DK233390D0 (da) 1990-09-27
AU3433189A (en) 1989-10-16
CA1331356C (en) 1994-08-09
KR900700609A (ko) 1990-08-16
AU621358B2 (en) 1992-03-12
EP0335243B1 (en) 1993-11-03
ATE96844T1 (de) 1993-11-15
ZA892270B (en) 1991-12-24
EP0335243A3 (en) 1989-11-23
EP0335243A2 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
DK233390A (da) Mutant humant angiogenin (angiogenese-faktor med hoej angiogeninaktivitet), gener derfor og metoder til ekspression
SE9102079D0 (sv) Purified ciliary neurotrophic factor
EP0155188A3 (en) Alpha-1-antitrypsin mutants and dna coding therefor and the production of each, and therapeutic formulations using such mutants and their preparation
BR9813202B1 (pt) complexo de administração de genes; processo de transdução de células com material genético estranho, composição útil para administração de material genético e uso de um complexo de administração de genes.
CA2066204A1 (en) Cystic fibrosis gene
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
WO1994010203A3 (en) Op-3-induced morphogenesis
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
NO171983C (no) Fremstilling av polypeptider med human-gammainterferon-aktivitet og dna-sekvens derav
EE200000152A (et) Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
EP0437610A4 (en) Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
EP0494702A3 (en) Production of factor xiiia by gene technology
ATE127840T1 (de) Charakterisierung und struktur der gene für protease a und protease b von streptomyces griseus.
NO984491D0 (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
DK587488A (da) Fibroblast-vaekstfaktor, nucleotidsekvens kodende derfor, praeparat indeholdende faktoren og fremgangsmaade til fremstilling deraf
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
BR1100940A (pt) Polipeptìdeos puros, sequências adn, molécula adn recombinada, célula hospedeira, processo de manipulação genética para produção de polipeptìdeo, e, uso de um polipeptìdeo
EP0274560A3 (en) Human hematopoietic cell growth potentiating factor
ZA887950B (en) Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions
AU5966790A (en) Genetic elements useful in production of active protein
Ries FEBS SPECIAL MEETING ON ENZYMES
IL88173A0 (en) Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment